OrthoCarolina Research Institute
Legal name: Orthocarolina Research Institute Inc
Nonprofit profile at a glance
- EIN
- 010648145
- IRS 990 coverage
- 2012–2024
- Official website data refreshed
- Sep 2026
- Forms available
- Form 990 2024
- Location
- Charlotte, NC, United States
- Phone
- 704-945-7710
- Rating
- 75
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Nerve, Muscle, Bone Diseases Research
Reported finances
- Revenue
- $2,643,097
- Expenses
- $2,078,142
- Assets
- $4,084,479
- Liabilities
- $485,673
Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
13 people listed
Executive titles in this filing
- CHRISTI CADD (EXECUTIVE DIRECTOR)
Highest reported compensation
- CHRISTI CADD (EXECUTIVE DIRECTOR): $181,466 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
EVERYDAY WE STRIVE TO MEET THE GROWING NEED FOR BETTER ORTHOPEDIC CARE THROUGH RESEARCH, INNOVATION, AND EDUCATION. The OrthoCarolina Research Advisory Committee (RAC) provides the day to day oversight, assistance, and guidance necessary to maintain research and educational activities consistent with the Institute’s mission. RAC meets bi-monthly to evaluate and approve/reject submitted research proposals based on scientific merit, suitability, and/or the impact on research support services at the Institute. Working with OCRI’s administrative staff, RAC establishes annual research and funding priorities, assesses research staffing and space utilization, oversees regulatory issues and ethics, and approves research policies and procedures. Research Advisory Committee Members.
What it reported doing in 2024
The institute's mission and priorities are centrally focused on (1) improved orthopedic patient care and (2) high quality evidence-based research to develop new and innovative orthopedic devices and technologies whose goal is to answer clinical questions for improved outcomes. The institute leads ongoing fda-regulated clinical trials and investigator-initiated scientific academic studies. Research is disseminated through peer reviewed journal publications with greater than 85 publications annually.
Operating model
- Revenue model
- Donor-supported. 77% of the money available for current operations came from contributions and gifts.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - A large share of total spending goes to programs and the filed numbers largely add up. A relatively small share of available resources goes toward mission work and fundraising costs are high for each dollar raised.
Rating breakdown
- Financial Efficiency: 61
- Transparency & Controls: 74
- Accountability: 100
- Sustainability: 65
- Growth: 100
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 58.4%; rating input score 58
- Program expense ratio: 68.4%; rating input score 68
- Fundraising efficiency: $16.27 raised per $1 spent on fundraising; rating input score 53; 53rd percentile among comparable filings
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
- Pay-setting controls: 2 of 6 controls in place; rating input score 33
- Compensation committee: Missing
- Independent consultant: Missing
- Other Form 990s reviewed: Missing
- Written employment contract: Pass
- Compensation survey or study: Pass
- Board or committee approval: Missing
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
- Governance controls: 8 of 8 controls in place; rating input score 100
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: Pass
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Pass
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: 21.4%; rating input score 78; 78th percentile among comparable filings
- Total-asset coverage ratio: 1.97; rating input score 61; 61st percentile among comparable filings
- Liabilities to assets ratio: 0.12; rating input score 55; 55th percentile among comparable filings
- Officer compensation ratio: 8.7%; rating input score 34; 34th percentile among comparable filings
Growth
- Program expense growth: 2.7% per year; rating input score 100; 26th percentile among comparable filings
- Revenue growth: 3.3% per year; rating input score 100; 29th percentile among comparable filings
- Asset growth: 4.6% per year; rating input score 100; 32nd percentile among comparable filings
Details
- What they do: 2 programs and campaigns described on the official site · 1 operating location identified
- Where the money goes: 58.4% of revenue deployed · 68.4% of spending went to programs
- Governance: 12 of 12 board members independent · 8 of 8 filing controls reported
- Programs: 3 filed program accomplishments · $1.4M in reported program spending
- Leadership: top reported pay $181K · 13 people listed · 2 of 6 pay-setting controls reported
- Consistency: 24 of 24 current checks pass
- Schedules: 5 filed schedules · includes major donors and executive pay
- Filing history: 12 filing years from 2012 to 2024
- Contacts: How to reach this organization
- Money network: 1 filed money-flow record
- Related organizations: Filed and resolved organization relationships.
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Review — Financial Efficiency: Mission deployment rate scored 58/100.
- Review — Financial Efficiency: Fundraising efficiency scored 53/100.
- Moderate — Sustainability: Officer compensation ratio scored 34/100.
- Review — Sustainability: Liabilities to assets ratio scored 55/100.